Be of value to patients and caregivers in forming a care plan for this challenging condition
Sumoda Achar, PharmD Candidate
Advertisement
Articles by Sumoda Achar, PharmD Candidate
Oncolytic polymers may be the answer to circumventing therapeutic resistance in cancer treatment.
Up to 81% of patients with cancer take medications to treat their other comorbidities.
As the resident medication experts, pharmacists are qualified to answer any medication-related questions and conduct data analyses.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nerandomilast Receives FDA Approval for Idiopathic Pulmonary Fibrosis
2
Study Shows Infliximab Biosimilar is Safe in Patients Undergoing RA Treatment
3
Dexamethasone-Sparing Regimen Offers Safer Option for Frail Patients With MM
4
Pneumococcal Polysaccharide Vaccination Does Not Reduce Rates of Cardiovascular Events
5
